CVS Health revenue and financials
$86.43Change from previous close: −0.67%Absolute change: −$0.58
In the fiscal year ended December 2025, CVS Health reported revenue of $402.07B (+7.85% year over year). Net income was $1.77B, a net margin of 0.4%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +7.85%
- 2025 vs 2024
- Net income growth
- −61.68%
- 2025 vs 2024
- Net margin
- 0.4%
- 2024: 1.2%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 105,455 | 99,852 | 105,099 | 102,239 | 98,428 | 94,068 | 96,955 | 94,878 | 90,840 | 87,983 | 93,545 | 89,487 |
| Cost of revenue | 90,347 | 84,802 | 92,126 | 89,065 | 85,322 | 80,192 | 84,811 | 82,870 | 77,851 | 75,876 | 79,937 | 76,187 |
| Gross profit | 15,108 | 15,050 | 12,973 | 13,174 | 13,106 | 13,876 | 12,144 | 12,008 | 12,989 | 12,107 | 13,608 | 13,300 |
| Selling, general and administrative | 11,036 | 10,932 | 11,321 | 10,858 | 10,347 | 10,584 | 10,364 | 10,499 | 10,236 | 10,130 | 10,170 | 9,782 |
| Operating income | 4,072 | 4,118 | 1,652 | 2,316 | 2,759 | 3,292 | 1,780 | 1,509 | 2,753 | 1,977 | 3,438 | 3,518 |
| EBIT | 4,072 | 4,118 | 1,652 | 2,316 | 2,759 | 3,292 | 1,780 | 1,509 | 2,753 | 1,977 | 3,438 | 3,518 |
| EBITDA | 5,198 | 5,233 | 2,799 | 3,450 | 3,930 | 4,446 | 2,927 | 2,670 | 3,904 | 3,115 | 4,572 | 4,645 |
| Interest expense | 757 | 774 | 787 | 784 | 763 | 785 | 758 | 752 | 732 | 716 | 690 | 693 |
| Pre-tax income | 3,977 | 3,938 | 1,354 | -3,482 | 1,647 | 2,617 | 2,126 | 105 | 2,337 | 1,580 | 2,705 | 3,019 |
| Income tax | 982 | 981 | -1,569 | 508 | 634 | 835 | 503 | 34.0 | 569 | 456 | 658 | 754 |
| Net income | 2,979 | 2,943 | 2,943 | -3,975 | 1,021 | 1,779 | 1,644 | 87.0 | 1,770 | 1,113 | 2,046 | 2,261 |
| Net income to common shareholders | 2,979 | 2,943 | 2,943 | -3,975 | 1,021 | 1,779 | 1,644 | 87.0 | 1,770 | 1,113 | 2,046 | 2,261 |
| Basic EPS | 2.33 | 2.31 | 2.32 | -3.13 | 0.81 | 1.41 | 1.31 | 0.07 | 1.41 | 0.88 | 1.59 | 1.76 |
| Diluted EPS | 2.31 | 2.30 | 2.31 | -3.13 | 0.80 | 1.41 | 1.31 | 0.07 | 1.41 | 0.88 | 1.59 | 1.75 |
| Average shares (basic) | 1,279 | 1,273 | 1,270 | 1,269 | 1,266 | 1,261 | 1,259 | 1,259 | 1,256 | 1,260 | 1,288 | 1,287 |
| Average shares (diluted) | 1,287 | 1,279 | 1,277 | 1,269 | 1,270 | 1,264 | 1,261 | 1,259 | 1,259 | 1,267 | 1,293 | 1,290 |
| Dividend per share | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 0.61 | 0.61 |